BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 3109733)

  • 1. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of mouse skin tumor promotion by chrysarobin.
    DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
    Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
    Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
    Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents.
    DiGiovanni J; Walker SC; Beltran L; Naito M; Eastin WC
    Cancer Res; 1991 Mar; 51(5):1398-405. PubMed ID: 1900038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter independence as a feature of most skin papillomas in SENCAR mice.
    Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
    Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promotion by a hydroperoxide metabolite of butylated hydroxytoluene, 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone, in mouse skin.
    Taffe BG; Kensler TW
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):291-303. PubMed ID: 3141995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
    Bhasin G; Kauser H; Athar M
    Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skin.
    Leyton J; Lee ML; Locniskar M; Belury MA; Slaga TJ; Bechtel D; Fischer SM
    Cancer Res; 1991 Feb; 51(3):907-15. PubMed ID: 1899048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
    Yokota K; Gill TJ; Shinozuka H
    Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
    Meeran SM; Vaid M; Punathil T; Katiyar SK
    Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of chrysarobin skin tumor promotion.
    DiGiovanni J; Kruszewski FH; Chenicek KJ
    Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice.
    DiGiovanni J; Boutwell RK
    Carcinogenesis; 1983; 4(3):281-4. PubMed ID: 6831635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.